Uniformly positive (>80%) HER2 expression maximizes sensitivity and specificity for prediction of response to trastuzumab in CALGB 9840
- Citation:
- Cancer Res vol 69 (2 Suppl 1) abstr 6046
- Meeting Instance:
- SABCS 2008
- Year:
- 2009
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- D. L. Rimm G. Broadwater P. N. Friedman D. A. Berry A. D. Seidman C. A. Hudis E. P. Winer L. N. Harris A. D. Thor
- Networks:
- Study
- CALGB-9840
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: